Knoepfler is STAT’s Lab Dish columnist and a professor of cell biology and human anatomy at UC Davis School of Medicine. De-extinction firm Colossal Biosciences announced Tuesday that it was acquiring ...

Dire wolves Romulus and Remus next to each other in the snow at five months old. Credit: Colossal Laboratories and Biosciences The sci-fi fairytale of de-extinction may become a reality. Colossal ...

Dallas biotech startup Colossal just got a little more sci-fi. The company behind efforts to de-extinct the woolly mammoth and other long gone species announced Tuesday its acquisition of Viagen, an ...

Opinions expressed by Digital Journal contributors are their own. While de-extinction often conjures images of scientific ambition divorced from conservation reality, Colossal Biosciences has ...